LINC-ROR and hepatocellular carcinoma: lncRNA-ROR was found to be enriched in human HepG2 and PLC/PRF/5 HCC cell-derived exosomes, and seemed to be involved in the mechanisms of sorafenib resistance; indeed, lncRNA-ROR levels increased during sorafenib treatment, and inhibited sorafenib-induced cell death [128].